Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression (2017)
- Authors:
- Lima, Hayana Ramos - Universidade de São Paulo (USP)
- Gasparoto, Thaís Helena - Universidade de São Paulo (USP)
- Malaspina, Tatiana Salles de Souza - Universidade de São Paulo (USP)
- Marques, Vinícius Rizzo - Universidade de São Paulo (USP)
- Vicente, Marina Jurado - Universidade de São Paulo (USP)
- Marcos, Elaine Camarinha
- Souza, Fabiana Corvolo
- Nogueira, Maria Renata Sales
- Barreto, Jaison Antônio
- Garlet, Gustavo Pompermaier
- Silva, João Santana da
- Brito-de-Souza, Vânia Nieto
- Campanelli, Ana Paula
- USP affiliated authors: GARLET, GUSTAVO POMPERMAIER - FOB ; SILVA, JOÃO SANTANA DA - FMRP ; CAMPANELLI, ANA PAULA - FOB
- Unidades: FOB; FMRP
- DOI: 10.3389/fimmu.2017.01724
- Subjects: IMUNOTERAPIA; HANSENÍASE; PROTEÍNAS DA MEMBRANA; LINFÓCITOS T
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 8, art. 1724, Dec. 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
LIMA, Hayana Ramos et al. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.01724. Acesso em: 04 ago. 2025. -
APA
Lima, H. R., Gasparoto, T. H., Malaspina, T. S. de S., Marques, V. R., Vicente, M. J., Marcos, E. C., et al. (2017). Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01724 -
NLM
Lima HR, Gasparoto TH, Malaspina TS de S, Marques VR, Vicente MJ, Marcos EC, Souza FC, Nogueira MRS, Barreto JA, Garlet GP, Silva JS da, Brito-de-Souza VN, Campanelli AP. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2025 ago. 04 ] Available from: https://doi.org/10.3389/fimmu.2017.01724 -
Vancouver
Lima HR, Gasparoto TH, Malaspina TS de S, Marques VR, Vicente MJ, Marcos EC, Souza FC, Nogueira MRS, Barreto JA, Garlet GP, Silva JS da, Brito-de-Souza VN, Campanelli AP. Immune checkpoints in leprosy: immunotherapy as a feasible approach to control disease progression [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2025 ago. 04 ] Available from: https://doi.org/10.3389/fimmu.2017.01724 - Elastase and cytokines in actinic cheilitis and oral squamous cell carcinoma
- CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses
- CCR5 mediates pro-osteoclastic and osteoclastogenic leukocyte chemoattraction
- Patients with Lepromatous Leprosy are characterized by increased frequency of suppressive regulatory T cells in the blood and lesions
- Inflammatory mediators in murine squamous cell carcinoma
- CCR5+ cells modulate RANKL+ cell migration, inflammatory reaction development and experimental periodontitis outcome in mice
- The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis
- Involvement of CCR5 and CXCR3 in RANKL+ cell migration and bone resorption throughout experimental periodontitis in mouse
- Associação diferencial de fatores genéticos, microbianos e inflamatórios com os níveis de MMP-1 no periodonto saudável e com periodontite
- IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis
Informações sobre o DOI: 10.3389/fimmu.2017.01724 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
